Afatinib vs Crizanlizumab

## Afatinib vs Crizanlizumab: Overview

This comparison examines the pharmacological differences between **Afatinib** and **Crizanlizumab**.

## Mechanism of Action

**Afatinib**: Irreversible covalent inhibitor of ErbB family (EGFR/HER1, HER2, HER4) tyrosine kinases.

## Pharmacokinetics

**Half-life**: Afatinib — 37 hours; Crizanlizumab — N/A.

## Chemical Properties

**Molecular Formula**: Afatinib — C24H25ClFN5O3; Crizanlizumab — N/A.

**Molecular Weight**: Afatinib — 485.9400 g/mol; Crizanlizumab — N/A.

**Type**: Afatinib — Small molecule; Crizanlizumab — Antibody.